Bausch’s Patents on Duobrii, Bryhali Psoriasis Drugs Upheld (1)

Bausch Health Cos. won a dispute over Padagis Israel Pharmaceuticals Ltd.’s copies of Bryhali and Duobrii, as a federal judge upheld the validity of four patents that block competition by generic rivals of the plaque psoriasis treatments for nine or more years.

Padagis had conceded ahead of an October bench trial that its proposed copies infringe the patents, a common legal tactic that allows accused infringers to focus on invalidity arguments.

Judge Stanley R. Chesler, in an opinion issued Thursday in the US District Court for the District of New Jersey, rejected Padagis’ arguments that two patents related ...